Egyszerű nézet

dc.contributor.author Kenessey, István
dc.contributor.author Simon E
dc.contributor.author Futosi, Krisztina
dc.contributor.author Bereczky, Bíborka
dc.contributor.author Kiss, Andrea
dc.contributor.author Erdődi, Ferenc
dc.contributor.author Gallagher JT
dc.contributor.author Tímár, József
dc.contributor.author Tóvári, József
dc.date.accessioned 2016-09-09T06:57:13Z
dc.date.available 2016-09-09T06:57:13Z
dc.date.issued 2009
dc.identifier 72949100109
dc.identifier.citation pagination=1265-1273; journalVolume=102; journalTitle=THROMBOSIS AND HAEMOSTASIS;
dc.identifier.uri http://repo.lib.semmelweis.hu//handle/123456789/3556
dc.identifier.uri doi:10.1160/TH09-01-0059
dc.description.abstract Heparin and its derivatives have been shown to inhibit angiogenesis and metastasis formation. Accordingly, we investigated the effect of heparin fragments containing 4 to 22 monomers on human melanoma cell proliferation, migration and invasion in vitro as well as on the in vivo metastatic potential in a SCID mouse model. Only oligosaccharide dp18 had significant inhibitory effect on cell proliferation. In contrast, cell migration was inhibited by all oligosaccharides studied except dp8 and dp22. Anti-CD44v3 antibody stimulated cell migration and invasion, and this effect could be attenuated by oligosaccharides dp4 and dp18. These fragments also inhibited the catalytic activity of myosin light chain phosphatase as well. Moreover, oligosaccharides dp4 and dp18 reduced the number of lung colonies formed in SCID mice intravenously injected with human melanoma cells, while dp22 proved to be ineffective in this respect. These studies revealed that fragments of heparin have an antimigratory and antimetastatic potential. These fragments lack the haemostatic effect of heparin, suggesting that they are potential specific antimetastatic agents in anticancer therapy. © 2009 Schattauer GmbH.
dc.relation.ispartof urn:issn:0340-6245
dc.title Antimigratory and antimetastatic effect of heparin-derived 4-18 unit oligosaccharides in a preclinical human melanoma metastasis model
dc.type Journal Article
dc.date.updated 2016-06-13T11:25:00Z
dc.language.rfc3066 en
dc.identifier.mtmt 1285626
dc.identifier.wos 000272973700034
dc.identifier.pubmed 19967160
dc.contributor.department DE/ÁOK/MTA-DE Sejtbiológiai és Jelátviteli Kutatócsoport
dc.contributor.department SE/AOK/I/II. Sz. Patológiai Intézet
dc.contributor.department DE/ÁOK/Orvosi Vegytani Intézet
dc.contributor.institution Debreceni Egyetem
dc.contributor.institution Semmelweis Egyetem


Kapcsolódó fájlok:

A fájl jelenleg csak egyetemi IP címről érhető el.

Megtekintés/Megnyitás

Ez a rekord az alábbi gyűjteményekben szerepel:

Egyszerű nézet